PHMMF (Pharma Mar) Days Inventory: 1,302.20 (As of Mar. 2026) — 69% Above Median


PHMMF Pharma Mar SA PHMMF
82 GF Score
Price $79.49
GF Value $90.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Pharma Mar Days Inventory?

Pharma Mar PHMMF -25.35% 82 Days Inventory is 1,302.20 as of Mar. 2026, which is 69% above its 10-year median of 771.33. GuruFocus rates PHMMF with a GF Score™ of 82/100 and a GF Value™ of $90.53 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Pharma Mar ranks worse than 92.79% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Pharma Mar's Average Total Inventories for the three months ended in Mar. 2026 was $60.4 Mil. Pharma Mar's Cost of Goods Sold for the three months ended in Mar. 2026 was $4.2 Mil. Hence, Pharma Mar's Days Inventory for the three months ended in Mar. 2026 was 1,302.20.

The historical rank and industry rank for Pharma Mar's Days Inventory or its related term are showing as below:

PHMMF' s Days Inventory Range Over the Past 10 Years
Min: 187.39   Med: 771.33   Max: 2011.11
Current: 1155.26

During the past 13 years, Pharma Mar's highest Days Inventory was 2011.11. The lowest was 187.39. And the median was 771.33.

PHMMF's Days Inventory is ranked worse than
92.79% of 638 companies
in the Biotechnology industry
Industry Median: 183.875 vs PHMMF: 1155.26

Pharma Mar's Days Inventory declined from Mar. 2025 (1,338.92) to Mar. 2026 (1,302.20).

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharma Mar's Inventory Turnover for the three months ended in Mar. 2026 was 0.07.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharma Mar's Inventory-to-Revenue for the three months ended in Mar. 2026 was 1.22.


Pharma Mar  (OTCPK:PHMMF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharma Mar's Inventory Turnover for the three months ended in Mar. 2026 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharma Mar's Inventory to Revenue for the three months ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Pharma Mar Days Inventory Related Terms


Pharma Mar Days Inventory Historical Data

* Premium members only.

The historical data trend for Pharma Mar's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Days Inventory Chart

Pharma Mar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 259.62 521.64 1,257.58 2,047.57 1,431.12

Pharma Mar Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,338.92 1,588.90 2,012.14 632.68 1,302.20

PHMMF vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Pharma Mar's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Days Inventory distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Days Inventory falls into.


PHMMF
82GF Score
Pharma Mar SA PHMMF
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharma Mar Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharma Mar's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (53.284 + 59.292) / 2 ) / 14.356*365
=56.288 / 14.356*365
=1,431.12

Pharma Mar's Days Inventory for the quarter that ended in Mar. 2026 is calculated as:

Days Inventory (Q: Mar. 2026 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (59.292 + 61.409) / 2 ) / 4.229*365 / 4
=60.3505 / 4.229*365 / 4
=1,302.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 1,302.20 mean?
Pharma Mar (PHMMF) has a Days Inventory of 1,302.20 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharma Mar and its competitors. This is 69% above median its historical median of 771.33. Over the past decade, Pharma Mar's Days Inventory has ranged from 187.39 to 2,011.11. According to the industry distribution chart, Pharma Mar ranks #592 out of 638 companies in the Biotechnology industry, placing it in the top 92.8%.
Is Pharma Mar's Days Inventory too high?
Pharma Mar's current Days Inventory of 1,302.20 is 69% above median its 10-year median of 771.33. Over the past 10 years, this metric has ranged from a low of 187.39 to a high of 2,011.11. The Biotechnology industry median Days Inventory is 183.88. Pharma Mar's value of 1,302.20 is 608.2% above this industry median. Based on the distribution chart, Pharma Mar ranks #592 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pharma Mar has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma Mar's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pharma Mar ranks #592 out of 638 companies for Days Inventory. This places Pharma Mar in the lower half of its industry. The industry median Days Inventory is 183.88. Pharma Mar's value of 1,302.20 is 608.2% above this benchmark. Historically, Pharma Mar's own Days Inventory has ranged from 187.39 to 2,011.11 over the past decade. While the company's 10-year median is 771.33 vs. the industry median of 183.88, Pharma Mar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.88, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma Mar's current Days Inventory of 1,302.20 is 608.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pharma Mar and its competitors. For the Biotechnology industry, the median Days Inventory is 183.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma Mar's current Days Inventory is 1,302.20, which is 69% above median its own 10-year median of 771.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma Mar stock overvalued right now?
Based on GuruFocus' analysis, Pharma Mar (PHMMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $90.53, compared to a current price of $79.49 — trading 12.2% below its estimated fair value. The current Days Inventory is 1,302.20, which is 69% above median its 10-year median of 771.33 and 608.2% above the Biotechnology industry median of 183.88. Pharma Mar's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pharma Mar (PHMMF), the current Days Inventory is 1,302.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharma Mar (PHMMF) Overvalued in 2026?

Based on GuruFocus' analysis, Pharma Mar stock appears to be undervalued. The current stock price of $79.49 is trading 12.2% below its estimated GF Value™ of $90.53. GuruFocus considers Pharma Mar to be Modestly Undervalued.

Key valuation signals for PHMMF:

  • Days Inventory: 1,302.20 (69% above median its 10-year median of 771.33)
  • GF Value™: $90.53 vs. price of $79.49 (12.2% below fair value)
  • GF Score™: 82/100 with 3 warning signs
  • Industry Position: 608.2% above the Biotechnology median (#592 of 638)

No single metric tells the full story. See the PHMMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharma Mar Business Description

Address Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.
82GF Score

Get the complete analysis for PHMMF

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$79.49
Price
$90.53
GF Value